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Abstract Familial hemiplegic migraine (FHM) type 1 is a
rare monogenic dominant autosomal disease due to CAC-
NA1A gene mutations. Besides the classical phenotype,
mutations on CACNA1A gene are associated with a broader
spectrum of clinical features including cerebellar ataxia,
making FHM1 a complex channelopathy. We report the case
of a patient carrying the p.Arg583Gln mutation affected by
hemiplegic migraine and late onset ataxia and we performed
a literature review about the clinical features of p.Arg583Gln.
Although p.Arg583Gln mutations are associated with a het-
erogeneous phenotype, carriers present cerebellar signs
which consisted generally in ataxia and dysmetria, with
intention tremor appearing mostly in advanced age, often
progressive and permanent. The heterogeneous spectrum of
CACNA1A gene mutations probably causes sporadic hemi-
plegic migraine (SHM) to be misdiagnosed. Given the ther-
apeutic opportunities, SHM/FHM1 should be considered in
differential diagnosis of patients with cerebellar ataxia and
migraine with aura.
Keywords FHM  SHM  Ataxia  Cerebellar 
CACNA1A
Introduction
Familial/sporadic hemiplegic migraine (FHM/SHM) is a
rare migraine with aura subtype, usually inherited in an
autosomal dominant manner [1]. Mutations on CACNA1A
on chromosome 19p13, (FHM1), ATP1A2 on chromosome
1q23 (FHM2) and SCN1A genes on chromosome 2q24
(FHM3) were identified as causing FHM [2, 3]. Missense
mutations in the CACNA1A gene, which encodes for the
alpha1 subunit of a P/Q type voltage-gated calcium channel,
account for 50–70 % of FHM patients [2]. Besides hemiplegic
migraine, FHM1 is associated with a broad spectrum of
clinical features [3, 4]. Cerebellar signs and symptoms,
ranging from nystagmus to progressive, usually late-onset,
mild ataxia, both during or independently from FHM/SHM
attacks, are also not uncommon in FHM1 families [3–9]. They
have been identified in up to 20–40 % of FHM1 families and
can become permanent and associated with cerebellar atrophy
at cerebral MRI in 60 % of affected individuals. Pathogenesis
of cerebellar involvement remains controversial. It has been
shown that different FHM mutations induce changes in single-
channel function and expression leading to opposite effects on
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Ca2? influx. Particularly, some authors observed that only
mutations causing a reduction of Ca2? influx are associated
with cerebellar ataxia in addition to the classical FHM phe-
notype, whereas in other papers cerebellar signs have been
associated with a gain of function in Ca2? receptor deter-
mining lower threshold and lower depolarization level [4, 10].
We report a 54-year-old woman, among the population of the
Lombardia GENS project (http://www.clinicaltrial.gov),
affected by migraine with aura and ataxia carrying the
p.Arg583Gln missense substitution in the CACNA1A gene
focusing, through a review literature, on the clinical pheno-
type of mutation carriers.
Case report
A 54-year-old woman (PV) was admitted in 2009 to the
Stroke Unit of Azienda Ospedaliera Ospedale di Circolo
di Busto Arsizio, Saronno, Tradate for recurrent attacks of
right temporal migraine followed by a sudden sequence
of left hemiparesis, associated with a decreased level of
consciousness, dysarthria, vision loss and sensory deficit
alternating in limb side. The neurological examination at
admission revealed a mild depression and a slight cognitive
deficit with a Minimental State Examination Score (MMSE)
of 27/30. No cranial nerve deficits, including dysarthria and
nystagmus, were detected. A slight left hemiparesis, mild
hypotonia in the four limbs and alternating arm deficit
in sensation were also observed. Cerebellar tasks showed
a bilateral dysmetria pattern at the nose–finger and heel–
shin test and inaccuracies were observed in fast alternating
hand movements (dysdiadochokinesia). Truncal ataxia and
intention tremor were not detected. Stance was achievable
without aid although the loss of balance and gait was ataxic,
but she was able to walk without help. From early childhood
she suffered from migraine with aura with a bi-monthly
frequency, mainly characterised by vision loss, sensory
deficit in the right limbs and sometimes, left hemiparesis.
Aura usually developed over a period of 5 min and lasted less
than 60 min. No triggers for symptoms onset or worsening
were identified. Biochemistry, inflammatory markers, thy-
roid hormones, cyanocobalamin dosage and autoantibodies
Fig. 1 a, b Coronal and axial T2-weighted images showing the small vascular lesion near the left silvian scissure (red arrow). c, d Axial and
sagittal T1 weighted images demonstrating cerebellar atrophy with deeper sulci on (color figure online)
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search (anti GAD, anti-glyadin, anti-endomysium, anti
neuronal) were negative. ECG, echocardiography and epi-
aortic and transcranial ultrasound examination were normal
too. The brain CT scan performed in the acute phase
demonstrated a hypodense round lesion proximal to the left
silvian fissure. The cerebral MRI confirmed the left hyper-
intense round lesion at T2 and FLAIR weighted images,
consistent with an old small ischemic infarction and revealed
a mild cerebellar atrophy (Fig. 1). Electroencephalogram
showed unspecific abnormalities on the left hemisphere,
consistent with lesional activity. During the hospitalization,
the patient’s left strength deficit as well as migraine pro-
gressively improved whereas cerebellar deficits remained
stable. Since the patient did not reported other hemiplegic
attacks at 1 year follow-up, no therapy was administered.
Familial history was not completely available given the
premature death of both parents. One brother had an
undocumented mental retardation. However, his neurologi-
cal examination was negative except for a bradypsychia.
Given the suspicion of sporadic hemiplegic migraine, a
genetic analysis for FHM1 and FHM2 was performed after
obtaining informed consent. Sequence analysis of CAC-
NA1A gene revealed the presence of the heterozygous
variant c.1748G[A, resulting in the p.Arg583Gln missense
substitution in the putative protein, already described in
association with hemiplegic migraine and ataxia (http://
grenada.lumc.nl/LOVD2/FHM/home.php).
Discussion
We report a patient presenting with migraine with aura and
cerebellar signs and symptoms, carrying the p.Arg583Gln
mutation in the CACNA1A gene. This mutation is located in
S4-transmembrane segments of a protein domain II, which is
considered the channel voltage sensor segment. The sub-
stitution of an arginine by a neutral glutamine determines a
change in the 3D structure and in the electrical activity of the
P/Q calcium channel, bringing a shift in activation and
inactivation dependence to a more negative potential. It is
also thought that the inactivation recovery of p.Arg583Gln
mutant is slower than normal, leading to accumulation of
many inactivated calcium channels during depolarization.
The mutation has been already described in about 30 patients
with hemiplegic migraine (HM) and ataxia [4–8], who are
summarized in Table 1. Phenotype of p.Arg583Gln carriers
seems to be quite heterogeneous and not always including
cerebellar ataxia. Some isolated and familial carriers have
been reported to be asymptomatic or presenting migraine
without ataxia [3–8]. This finding is consistent with an
incomplete disease penetrance or alternatively with the late
disease onset [3, 6], given the young age of most asymp-
tomatic cases. However, despite the heterogeneous
phenotypic spectrum, some common characteristics can be
drawn. First, cerebellar signs appeared mostly in advanced
age and mainly consisted in ataxia and dysmetria with
intention tremor, whereas nystagmus was never described
[3, 7]. Second, in most cases cerebellar signs are progressive
and permanent making the phenotype of p.Arg583Gln
mutations more similar to SCA6 than EA2. Lastly, except
for a few cases in which migraine was triggered by fever or
head trauma, in most cases, a provoking event was not
detectable [5, 7]. Our case, except for relatively small attack
duration, does not differ from other literature observations.
However, the small number of reported patients and the lack
of neuroimaging data make it difficult to define a clearer
p.Arg583Gln phenotype. Interestingly, acetazolamide
seems to be effective in p.Arg583Gln symptomatic carriers
[7]. The availability of therapeutic options supports genetic
screening for FHM/SHM also in atypical form of hemiplegic
migraine with cerebellar symptoms after exclusion of other
possible causes.
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